| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...734865Z |
| P356 | DOI | 10.1371/JOURNAL.PONE.0034865 |
| P932 | PMC publication ID | 3329547 |
| P698 | PubMed publication ID | 22529945 |
| P5875 | ResearchGate publication ID | 224822088 |
| P50 | author | Youmin Kang | Q56642581 |
| P2093 | author name string | Ming Wang | |
| Bin Wang | |||
| Yi Jin | |||
| Bing Wu | |||
| Xiaoping Xie | |||
| Yanxin Hu | |||
| Yizhi Zhang | |||
| Qiang Zou | |||
| Xiaoxuan Liang | |||
| Di Meng | |||
| Jia Xue | |||
| Xiaoxu Fan | |||
| Xianzheng Wang | |||
| Xianghua Shi | |||
| Congcong Feng | |||
| P2860 | cites work | Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals | Q24648051 |
| Praziquantel facilitates IFN-γ-producing CD8+ T cells (Tc1) and IL-17-producing CD8+ T cells (Tc17) responses to DNA vaccination in mice | Q28477371 | ||
| Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice | Q28749625 | ||
| Autophagy-dependent viral recognition by plasmacytoid dendritic cells | Q29614177 | ||
| Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors | Q30230269 | ||
| Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. | Q30328341 | ||
| The genesis of a pandemic influenza virus. | Q30351764 | ||
| Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. | Q30352066 | ||
| Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. | Q30357081 | ||
| Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. | Q30362794 | ||
| Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. | Q30366836 | ||
| Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus | Q30368335 | ||
| An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice | Q30390234 | ||
| Cytotoxic T-cell immunity to influenza. | Q55062679 | ||
| Aluminium-containing DTP vaccines | Q57272297 | ||
| MF59™ as a vaccine adjuvant: a review of safety and immunogenicity | Q30394545 | ||
| Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection | Q30398435 | ||
| Human cytotoxic T-lymphocyte repertoire to influenza A viruses | Q33785232 | ||
| Avian influenza A (H5N1) in 10 patients in Vietnam | Q34301283 | ||
| Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus | Q34468698 | ||
| Influenza vaccines: present and future | Q34717840 | ||
| Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virus | Q34858946 | ||
| Praziquantel | Q35156550 | ||
| Influenza A H5N1 replication sites in humans | Q36022034 | ||
| Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells | Q36230446 | ||
| Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge | Q36231145 | ||
| Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles | Q36363946 | ||
| Influenza and the challenge for immunology | Q36452600 | ||
| Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge | Q37155421 | ||
| Type 17 CD8+ T cells display enhanced antitumor immunity. | Q37268980 | ||
| IL-23 promotes the production of IL-17 by antigen-specific CD8 T cells in the absence of IL-12 and type-I interferons. | Q37313268 | ||
| Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species | Q39509861 | ||
| Inhibition of highly pathogenic avian H5N1 influenza virus propagation by RNA oligonucleotides targeting the PB2 gene in combination with celecoxib | Q39568389 | ||
| Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus | Q39584981 | ||
| The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. | Q39685999 | ||
| A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity | Q39835072 | ||
| Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6. | Q40132546 | ||
| Switch of CD8 T cells to noncytolytic CD8-CD4- cells that make TH2 cytokines and help B cells. | Q41547198 | ||
| In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes | Q41771574 | ||
| Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. | Q41899031 | ||
| Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. | Q42739331 | ||
| Enhancement of humoral and cellular responses to HBsAg DNA vaccination by immunization with praziquantel through inhibition TGF-beta/Smad2,3 signaling | Q43147995 | ||
| A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression | Q43874050 | ||
| Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. | Q44516991 | ||
| Cellular immune responses of mice to influenza virus vaccines | Q44788757 | ||
| Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin | Q45397691 | ||
| Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model | Q45407370 | ||
| IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. | Q45987254 | ||
| Boosting our best shot | Q47913347 | ||
| IL-23 drives pathogenic IL-17-producing CD8+ T cells. | Q47976537 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| praziquantel | Q424145 | ||
| P304 | page(s) | e34865 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Use of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in mice | |
| P478 | volume | 7 |
| Q34193058 | CD8+ Treg cells suppress CD8+ T cell-responses by IL-10-dependent mechanism during H5N1 influenza virus infection. |
| Q33578026 | Cimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell |
| Q100517406 | DNA adjuvant Amiloride conjunct long immunization interval promote higher antibody responses to HIV-1 gp41 and gp140 immunogens |
| Q64085671 | Decreased Frequencies of Th17 and Tc17 Cells in Patients Infected with Avian Influenza A (H7N9) Virus |
| Q38328539 | IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity. |
| Q34290857 | Nizatidine, a small molecular compound, enhances killed H5N1 vaccine cell-mediated responses and protects mice from lethal viral challenge |
Search more.